Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantSHOEI UNIVERSAL CORPORATION PTE LTD
Licence HolderSHOEI UNIVERSAL CORPORATION PTE LTD
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
INTRAVENOUS
Medical Information
V03AB04
pralidoxime
Manufacturer Information
SHOEI UNIVERSAL CORPORATION PTE LTD
ILDONG PHARMACEUTICAL CO., LTD